Antiplatelet agents and extracorporeal circulation
Open Access
- 1 May 1980
- journal article
- editorial
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 3 (3), 129-132
- https://doi.org/10.1177/039139888000300302
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILUREThe Lancet, 1980
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979
- PROSTACYCLIN: A SOLUTION TO SOME PROBLEMS OF EXTRACORPOREAL CIRCULATIONThe Lancet, 1979
- PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGSThe Lancet, 1978
- Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.Gut, 1977
- Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogsEuropean Journal of Clinical Investigation, 1977
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- REDUCTION OF THROMBUS FORMATION ON DIALYSER MEMBRANES BY ASPIRIN AND RA 233The Lancet, 1972
- Haemostatic Changes during Dialysis Associated with Thrombus Formation on Dialysis MembranesBMJ, 1972